MAIA Biotechnology, Inc.MAIAEarnings & Financial Report
NYSE
MAIA Q3 2022 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-4.0M
Net Profit
$-3.9M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.49
MAIA Biotechnology, Inc. Q3 2022 Financial Summary
MAIA Biotechnology, Inc. reported revenue of $0 for Q3 2022, with a net profit of $-3.9M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-3.9M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q3 2022 |
Income Statement
| Q3 2022 | |
|---|---|
| Revenue | $0 |
| YoY Growth | N/A |
Balance Sheet
| Q3 2022 | |
|---|---|
| Assets | $14.8M |
| Liabilities | $2.5M |
| Equity | $12.3M |
Cash Flow
| Q3 2022 | |
|---|---|
| Operating CF | $-4.3M |